Immunosuppression withdrawal
Immunosuppression withdrawal is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation
Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
Clinical Trials (7)
Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation
Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7